Ebola Outbreak in Ituri Province, DRC

A confirmed Ebola Virus Disease outbreak has been reported in Democratic Republic of the Congo — Ituri Province, Democratic Republic of the Congo, with 246 suspected cases and 65 deaths. Preliminary laboratory results from France — Inserm indicate a non-Zaire ebolavirus strain. United States — Centers for Disease Control and Prevention is closely monitoring the situation and has convened an urgent high-level coordination meeting on May 15, 2026, with health authorities from Democratic Republic of the Congo, Uganda, and South Sudan, along with key international partners including World Health Organization, UNICEF, United States — Centers for Disease Control and Prevention, European Union — European Centre for Disease Prevention and Control, United States — Centers for Disease Control and Prevention, Canada — Public Health Agency of Canada, and pharmaceutical companies such as Gilead Sciences, Merck & Co., Johnson & Johnson, Regeneron Pharmaceuticals, Roche, Abbott Laboratories, Danaher Corporation — Cepheid variable, BioNTech, Moderna, and Evotec. The meeting aims to strengthen cross-border coordination, surveillance, laboratory support, infection prevention and control, risk communication, and resource mobilization to contain the spread, which is complicated by intense population movement, mining-related mobility, and insecurity in affected areas.